Europe - Euronext Milan - BIT:1HOLX - US4364401012 - Common Stock
The current stock price of 1HOLX.MI is 56.5 EUR.
ChartMill assigns a technical rating of 1 / 10 to 1HOLX.MI.
ChartMill assigns a fundamental rating of 6 / 10 to 1HOLX.MI. 1HOLX.MI gets an excellent profitability rating and is at the same time showing great financial health properties.
Over the last trailing twelve months 1HOLX.MI reported a non-GAAP Earnings per Share(EPS) of 3.59. The EPS increased by 7.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.83% | ||
| ROA | 6.51% | ||
| ROE | 12.05% | ||
| Debt/Equity | 0.54 |
For the next year, analysts expect an EPS growth of 4.53% and a revenue growth 1.24% for 1HOLX.MI
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. The company is headquartered in Marlborough, Massachusetts and currently employs 7,063 full-time employees. The firm is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
HOLOGIC INC
250 Campus Drive
Marlborough MASSACHUSETTS US
Employees: 7063
Phone: 15082632900
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. The company is headquartered in Marlborough, Massachusetts and currently employs 7,063 full-time employees. The firm is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
The current stock price of 1HOLX.MI is 56.5 EUR. The price decreased by -0.88% in the last trading session.
1HOLX.MI does not pay a dividend.
1HOLX.MI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
1HOLX.MI stock is listed on the Euronext Milan exchange.
The Revenue of HOLOGIC INC (1HOLX.MI) is expected to grow by 1.24% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
HOLOGIC INC (1HOLX.MI) has a market capitalization of 12.59B EUR. This makes 1HOLX.MI a Large Cap stock.